Defence Therapeutics Inc. (DTCFF)
OTCMKTS · Delayed Price · Currency is USD
0.4200
-0.0282 (-6.29%)
At close: Feb 11, 2026
Defence Therapeutics Market Cap
Defence Therapeutics has a market cap or net worth of $24.41 million as of February 12, 2026. Its market cap has increased by 5.09% in one year.
Market Cap
24.41M
Enterprise Value
24.89M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.42
Market Cap Chart
Since May 7, 2021, Defence Therapeutics's market cap has decreased from 73.36M to 24.41M, a decrease of -66.73%. That is a compound annual growth rate of -20.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 23.22M | -22.93% |
| Dec 31, 2025 | 30.13M | 37.69% |
| Dec 31, 2024 | 21.88M | -72.11% |
| Dec 29, 2023 | 78.46M | 7.90% |
| Dec 30, 2022 | 72.71M | -52.72% |
| Dec 31, 2021 | 153.80M | 109.65% |
| May 7, 2021 | 73.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arch Biopartners | 43.72M |
| ZIVO Bioscience | 40.17M |
| Cell Source | 38.23M |
| Harvard Apparatus Regenerative Technology | 31.12M |
| Oncotelic Therapeutics | 27.82M |
| EOM Pharmaceuticals Holdings | 22.63M |
| Finch Therapeutics Group | 22.08M |
| Zenith Capital | 20.77M |